It does not cover mild OSA, people without obesity, central sleep apnea, or children
The broader picture is that the next generation of obesity treatments involves multi-target approaches, whether through single molecules activating multiple receptors (tirzepatide, retatrutide, survodutide, mazdutide) or through combination therapies pairing separate compounds (CagriSema)
Expert Opinions and Advice Experts recommend that you stay in touch with your healthcare provider during your treatment
No clinical evidence supports this claim
This is particularly important for individuals with type 2 diabetes, who are at increased risk for heart disease
After going to InfusaLounge and discussing my goals, I set up a telehealth consultation with one of their licensed medical professionals